Literature DB >> 24025108

A case-control study of elective hip surgery among HIV-infected patients: exposure to systemic glucocorticoids significantly increases the risk.

E Kerr1, A Middleton, D Churchill, I Reading, K Walker-Bone.   

Abstract

OBJECTIVES: This was a cross-sectional study with a nested case-control analysis among a cohort of HIV-infected adults aiming to explore the prevalence of and risk factors for elective hip surgery (total hip arthroplasty and resurfacing).
METHODS: Cases were identified from the out-patient database of HIV-infected adults attending one tertiary hospital service. For each case, five controls from the same database matched by age, gender and ethnicity were identified. From the case notes, information about demographic factors, HIV factors and risk factors for hip surgery attributable to osteoarthritis or avascular necrosis (body mass index, lipids, alcohol, comorbidities and treatment with oral glucocorticoids) was extracted.
RESULTS: Among the cohort of 1900 HIV-infected out-patients, 13 cases (12 male) who had undergone hip surgery [0.7%; 95% confidence interval (CI) 0.3-1.1%] were identified, with a median age of 47 years. Eleven of the 13 cases (85%) were Caucasian and seven of the 13 were in stage 3 of HIV infection. Fewer of the cases were in the asymptomatic stage of infection compared with controls [odds ratio (OR) for stage 2 or 3 infection 4.0; 95% CI 0.8-18.5]. Ever having used oral glucocorticoids was highly significantly associated with elective hip surgery (OR 44.6; 95% CI 5.7-347.7).
CONCLUSIONS: Among this young cohort, the prevalence of elective hip surgery was 0.7%, with the median age at surgery being 47 years. Ever having been exposed to systemic glucocorticoids was highly significantly associated with elective hip surgery, suggesting that the principal mechanism underlying the need for surgery was avascular necrosis. There may be an increased need for elective hip surgery associated with HIV infection.
© 2013 British HIV Association.

Entities:  

Keywords:  HIV; avascular necrosis; elective total hip replacement; glucocorticoids; hip resurfacing; osteoarthritis

Mesh:

Substances:

Year:  2013        PMID: 24025108      PMCID: PMC5362063          DOI: 10.1111/hiv.12084

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


  18 in total

1.  The use of alendronate in the treatment of avascular necrosis of the femoral head: follow-up to eight years.

Authors:  S Agarwala; S Shah; V R Joshi
Journal:  J Bone Joint Surg Br       Date:  2009-08

2.  Antiretroviral treatment and osteonecrosis in patients of the Swiss HIV Cohort Study: a nested case-control study.

Authors:  Barbara Hasse; Bruno Ledergerber; Matthias Egger; Markus Flepp; Stefano Bachmann; Enos Bernasconi; Martin Egger; Sophie Guyot; Bernard Hirschel; Rainer Weber; Huldrych F Günthard
Journal:  AIDS Res Hum Retroviruses       Date:  2004-09       Impact factor: 2.205

3.  Osteonecrosis in patients infected with human immunodeficiency virus: a case-control study.

Authors:  M J Glesby; D R Hoover; C M Vaamonde
Journal:  J Infect Dis       Date:  2001-07-18       Impact factor: 5.226

4.  Avascular necrosis in HIV-infected patients: a case-control study from the Aquitaine Cohort, 1997-2002, France.

Authors:  Sylvie Lawson-Ayayi; Fabrice Bonnet; Elise Bernardin; Jean-Marie Ragnaud; Denis Lacoste; Denis Malvy; Marie-Josée Blaizeau; Ghada Miremont-Salamé; Michel Dupon; Patrick Mercié; François Dabis
Journal:  Clin Infect Dis       Date:  2005-03-18       Impact factor: 9.079

5.  Osteonecrosis in human immunodeficiency virus (HIV)-infected patients: a multicentric case-control study.

Authors:  Elena Mazzotta; Adriana Agostinone; Raffaella Rosso; Antonio Di Biagio; Giuseppe Vittorio De Socio; Anna Cappelletti; Raffaele Zicolella; Ennio Polilli; Paolo Bonfanti; Luigi Di Matteo; Lamberto Manzoli; Giustino Parruti
Journal:  J Bone Miner Metab       Date:  2011-01-22       Impact factor: 2.626

6.  Risk factors for total hip replacement due to primary osteoarthritis: a cohort study in 50,034 persons.

Authors:  Gunnar B Flugsrud; Lars Nordsletten; Birgitte Espehaug; Leif I Havelin; Haakon E Meyer
Journal:  Arthritis Rheum       Date:  2002-03

7.  Thrombophilia in human immunodeficiency virus-infected patients with osteonecrosis: Is there a real connection? The first case-control study.

Authors:  Gabriela de Larrañaga; Edgardo Bottaro; Marta Martinuzzo; Raúl Figueroa; María Luisa Iglesias Varela; Silvia Perés Wingeyer; Ricardo Forastiero; Yolanda Adamczuk; Marcelo Corti; Liliana Puga; Jorge Benetucci
Journal:  Clin Appl Thromb Hemost       Date:  2007-12-26       Impact factor: 2.389

8.  Metabolic derangement after injection of triamcinolone into the hip of an HIV-infected patient receiving ritonavir.

Authors:  Patrick J Danaher; Thomas L Salsbury; Judith A Delmar
Journal:  Orthopedics       Date:  2009-06       Impact factor: 1.390

9.  Role of obesity on the risk for total hip or knee arthroplasty.

Authors:  Robert Bourne; Shaheena Mukhi; Naisu Zhu; Margaret Keresteci; Mihaela Marin
Journal:  Clin Orthop Relat Res       Date:  2007-12       Impact factor: 4.176

Review 10.  Resurfacing versus conventional total hip arthroplasty - review of comparative clinical and basic science studies.

Authors:  David R Marker; Kyle Strimbu; Mike S McGrath; Michael G Zywiel; Michael A Mont
Journal:  Bull NYU Hosp Jt Dis       Date:  2009
View more
  2 in total

Review 1.  Assessment and management of musculoskeletal disorders among patients living with HIV.

Authors:  Karen Walker-Bone; Erin Doherty; Kaushik Sanyal; Duncan Churchill
Journal:  Rheumatology (Oxford)       Date:  2017-10-01       Impact factor: 7.580

2.  Sepsis risk factors associated with HIV-1 patients undergoing surgery.

Authors:  Tienan Feng; Xiuling Feng; Chenghua Jiang; Chaogang Huang; Baochi Liu
Journal:  Emerg Microbes Infect       Date:  2015-09-23       Impact factor: 7.163

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.